1. HOME
2. Research Insight
3. DeLaval (Sweden) and Zoetis Inc. (US) are Leading Players in the Udder Health Market

The global udder health market is projected to reach USD 1.6 billion by 2029 from USD 1.2 billion in 2024 at a CAGR of 5.9%.

The Udder Health Market focuses on products and solutions to maintain and improve the udder health of dairy cattle. This market includes devices for udder care, pharmaceuticals to treat infections like mastitis, and supplements to boost udder health and milk production rate. The devices segment includes tools for sampling milk, checking milk quality, analyzing somatic cell count, while the pharmaceutical segment covers medicines like antibiotics, vaccines and intra-mammary infusions and the supplement segment offers vitamins, minerals, and other health products for lactating animals.

To know about the assumptions considered for the study download the pdf brochure

The prominent players of global endoscopy equipment market are Vetoquinol S.A. (France), Zoetis Inc. (US), Merck & Co., Inc. (US), Virbac (France), Ecolab (US), Boehringer Ingelheim GmbH (Germany), Elanco Animal Health Incorporated (US), DeLaval (Sweden), Orffa (Netherlands), AHV International (Netherlands), Boumatic LLC (US), GEA Group Aktiengesellschaft (Germany), G Shepherd Animal Health (UK), and Ceva Sante Animale (France), Albert Kerbl GmbH (Germany), Ambic Equipment Limited (England), Lely (Netherlands), Zenex Animal Health India Private Limited (India), Draminski S.A. (Poland), Ring Biotechnology Co Ltd. (China), Nicosia Biolabs International Private Limited (India), Blackmango Herb (India), Koru Diagnostics Ltd. (New Zealand), Mastaplex (New Zealand), and AR Brown Co., Ltd. (Japan). These companies adopted strategies such as product launches, partnerships, acquisitions, and expansions to strengthen their presence in the endoscopy equipment market.

DeLaval (Sweden)

Tetra Laval comprises Tetra Pak, Sidel, and DeLaval, with DeLaval specializing in dairy farming solutions. Based in Tumba, Sweden, DeLaval is renowned for its dairy equipment across various segments: Milking, Hygiene, Service, and Farm Supplies. The Hygiene division focuses on udder health, offering diagnostic tools, teat dips, and cleaning products. Operating globally, DeLaval serves over 100 markets, prominently in dairy-rich regions such as the USA, Canada, Germany, France, China, and Brazil. Its subsidiaries include Delaval Inc. (USA), DeLaval Ltd. (UK), and DeLaval Pty Ltd. (Australia), highlighting its extensive international footprint in the dairy industry. In July, 2020, DeLaval acquired Milkrite | InterPlus, a successful company with a strong brand and trademark portfolio acknowledged by dairy farmers across the world. The company is a global leader providing complete milking point solutions to dairy farmers.

Zoetis Inc. (US)

Zoetis, a leading global entity in animal health, focuses on discovering, developing, manufacturing, and marketing vaccines and medicines for both livestock and companion animals. Organized into three main segments—Companion Animals, Livestock, and Contract Manufacturing and Human Health—the company provides a variety of intramammary antibiotic therapies crucial for treating clinical and subclinical mastitis in dairy cows, within its Livestock segment. Operating across four key geographic regions—the US; Europe, Africa, and the Middle East; Canada and Latin America; and the Asia Pacific—Zoetis conducts business in 70 countries, with its products available in over 120 countries via extensive distribution networks. Notable subsidiaries include Allabing de Mexico, S.A. de C.V., Alpharma Animal Health Company (US), Fort Dodge Asia Exports, Inc. (US), Jilin Pfizer Guoyuan Animal Health Co., Ltd. (China), Alpharma do Brasil Ltda., and Alpharma Canada Corporation. In March, 2024, ZOETIS INC purchased a 21-acre manufacturing site in Melbourne (Australia) to expand its operations and increase and manufacture vaccines for sheep, cattle, dogs, cats and horses.

Boehringer Ingelheim GmbH (Germany)

Boehringer Ingelheim, a prominent pharmaceutical company, manufactures a wide range of products including pharmaceuticals for humans and animals. Its operations are structured into Human Pharma, Animal Health, Biopharmaceutical Contract Manufacturing, and Other Sales segments. In Animal Health, the company offers a diverse portfolio encompassing biological, natural, and pharmaceutical care products, notably parasiticides for both food-producing and companion animals. Boehringer Ingelheim maintains a global presence through 146 subsidiaries worldwide, such as Boehringer Ingelheim Pharmaceuticals, Inc. (US), Boehringer Ingelheim Backmittel GmbH (Germany), Boehringer Ingelheim Pty. Ltd. (Australia), Boehringer Ingelheim SpA (Italy), Boehringer Ingelheim Corporation (Japan), Boehringer and Cia Ltda. (Brazil), and Boehringer Ingelheim SA de CV (Mexico).

Related Reports:

Udder Health Market by Product (Pharmaceuticals (Antibiotics, Intramammary Infusions), Devices (Milk Quality Analysers), Supplements)), Veterinary Care Settings (Dairy Farms, Veterinary Hospitals & Clinics), Animal Type - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]